2012
DOI: 10.1016/j.meegid.2011.10.018
|View full text |Cite
|
Sign up to set email alerts
|

Identification of human papillomavirus type 53 L1, E6 and E7 variants in isolates from Brazilian women

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2013
2013
2016
2016

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 23 publications
0
3
0
Order By: Relevance
“…The oncogenic E6 and E7 proteins are commonly mutated, whereas synonymous and nonsynonymous mutations are also reported in the L1 gene in HPV 16 [25][26][27]. Several studies investigated the genetic variability of L1, E6, and E7 genes in HPV 18, 38, 52, and 53 and showed that the intratypic variants were frequently found [28][29][30][31]. Some of these mutations increased the oncogenic potential and the infection efficiency of the viruses.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The oncogenic E6 and E7 proteins are commonly mutated, whereas synonymous and nonsynonymous mutations are also reported in the L1 gene in HPV 16 [25][26][27]. Several studies investigated the genetic variability of L1, E6, and E7 genes in HPV 18, 38, 52, and 53 and showed that the intratypic variants were frequently found [28][29][30][31]. Some of these mutations increased the oncogenic potential and the infection efficiency of the viruses.…”
Section: Resultsmentioning
confidence: 99%
“…Persistent infection with high-risk Alpha PVs is a prerequisite for the development of cervical cancer and its histological precursor, cervical intraepithelial lesions. Twelve HPVs (16,18,31,33,35,39,45, 51, 52, 56, 58, and 59) are classified by the International Agency for Research on Cancer as being carcinogenic to humans, with HPV 68 being recognized as probably carcinogenic. Several other HPV types (26,30,34,53,66,67,69,70,73,82,85, and 97) are possibly carcinogenic based on evolutionary similarity to the known cancer-causing types [3].…”
Section: Introductionmentioning
confidence: 99%
“…estimated potential for progression to malignancy and are both highly genetically diverse with distinct intratype variants [6][7][8][9]. There is currently no evidence that L1 polymorphisms are associated with cervical malignancy but the diversity of these types and their worldwide distribution are striking [10][11][12][13]. While the detection of HPV66 is currently included in the majority of commercially available tests for cervical cancer screening, convincing data on the clinical significance and malignant potential of HPV53 are lacking [14,15].…”
mentioning
confidence: 99%